The FDA approved esketamine, an experimental nasal spray that delivers the active ingredients of the “club drug” ketamine, as a new treatment for severe depression.
who experience suicidal thoughts, but patients are required to see a provider for treatment. Experts believe that the FDA approval of a quick-acting, easy-to-use spray treatmentis a pivotal moment in the history of mental health therapy.
Esketamine, which will be marketed under the trade name, Sparavato is an experimental nasal spray that delivers the active ingredients of the “club drug” ketamine. It was approved as a new treatment for severe depression by the Food and Drug Administration Tuesday.Drugmakers believe the spray can help 30 to 40 percent of patients who don't respond to antidepressants.
Depression is very common. Around the world, 300 million people are affected and almost 800,000 commit suicide, according to the.
In February, a federal advisory panel said the benefits of the nasal spray outweighed the risks. The panel noted that “We're a long way from this being an at-home or over-the-coutner drug. Drug diversion is a real concern for this class of drug, but the plan is that the drug would be given to providers plan who would then administer the drug to patients on-site,” Sanacora said.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
FDA approves nasal spray for depressionCNN News, delivered. Select from our newsletters below and enter your email to subscribe.
Leer más »
Man's blocked nose turned out to be a tooth growing in his nasal cavityCase is one of just a handful of reports of “intranasal teeth.”
Leer más »
Reynolds tobacco debuts e-cigarette commercial, tightens online vape sales to combat teen useReynolds is also tightening online sales as the FDA weighs e-cigarette regulations.
Leer más »
Silicon Valley just lost a friend with the exit of Gottlieb from the FDASilicon Valley's tech companies like Apple and Alphabet had an ally in FDA commissioner Scott Gottlieb.
Leer más »
FDA warns Canadian drug distributor about sending ‘unsafe’ drugs to U.S.A CanaRx representative said he was baffled by the action, saying it facilitates sales of “American brand-name drugs only.”
Leer más »
FDA Commissioner Scott Gottlieb is resigning
Leer más »
FDA puts 15 national retailers on notice for allegedly selling tobacco products to minorsThe Food and Drug Administration called out 15 retailers on Monday for allegedly selling tobacco products to minors.
Leer más »
CVS closes hearing centers as FDA readies rules for over-the-counter sales of hearing aidsCVS is pivoting ahead of changes that could reshape the hearing aid market. Next year, the FDA will introduce regulations to bring hearing aids over the counter. CVS is also experimenting with new store formats.
Leer más »